Study of polg-related disease over time
Part of Bones, joints & muscles, Brain & nervous system, Eyes & vision, Hormones & metabolism clinical trials.
This study follows people of all ages with a confirmed POLG-related disease to learn how the condition changes over time. The information collected may help design better care and future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Are aged 0 to 75 years old
- Have a confirmed diagnosis of a POLG-related disease, based on both genetic testing and symptoms
- Do not have a different mitochondrial disease, and your genetic changes are known to cause disease
- Are willing to participate in study visits and follow-up procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have an HPDL gene change to better understand how symptoms and health progress over time. It may help clinicians learn more about the condition and plan future treatments.
This natural history study follows children and adults with suspected or confirmed mitochondrial myopathy to better understand symptoms and how the condition changes. It may also include healthy participants to compare test results and improve future treatments.
This study observes people with primary mitochondrial muscle diseases over time to better understand how symptoms change. It may help improve future care by learning patterns of muscle weakness, fatigue, and related complications.
This study follows children with Pelizaeus-Merzbacher disease (PMD) who have a specific genetic change (PLP1 duplication). It aims to learn which body measurements (“biomarkers”) and symptoms change over time, to better understand disease progression.
This study collects blood and skin samples from people with primary mitochondrial disease and from healthy volunteers. The samples will help researchers better understand these diseases and develop future treatments.
This study looks at how metabolism, infections, and the immune system work together in people with mitochondrial disease. It aims to learn more about the condition and may help guide future treatments.
Hear when a new PolG, Primary Mitochondrial Myopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.